NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 6 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Capillary Tech Q2 FY27 Earnings Call: Organic NRR at 116%, Session M Paid $2M for ₹300 Cr Scale
Capillary Technologies reported its Q2 FY27 earnings conference call transcript, noting an organic Net Retention Rate (NRR) of 116% (109% constant currency). The company outlined its inorganic growth strategy, highlighting the Session M acquisition where it paid around $2 million for a ~₹300 crore revenue business, supported by approximately ₹500 crore in available cash. Management reaffirmed that full-year performance will meet or exceed previously stated guidance, backed by multi-year recurring enterprise contracts across 55 countries.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the verbatim transcript for the Q2 FY27 earnings conference call held on November 02, 2026.
ஏன் இது முக்கியம்Provides operational details regarding organic retention metrics, AI-led platform expansion (aiRA), and M&A discipline against the company's ₹811 crore TTM revenue base.
Organic NRR (Q2): 116%Constant Currency NRR: 109%Cash on books: around 500 croresSession M acquisition cost: 2 mnCAC payback period: 16-17 மாதங்கள்
📅 குறுகிய காலம்Routine earnings transcript; markets will focus on whether guidance execution can improve profitability following Jun 2026 net losses.
📈 நீண்ட காலம்Sustainable upside depends on retaining customers via aiRA upselling, quick API migrations for inorganic buyouts, and operating leverage.
High institutional investor dissent previously observed around equity dilution/ESOP schemes
👀 கவனிக்க வேண்டியவை
Track the integration efficiency and revenue contribution of acquired assets like Session M and Customer Glue, alongside margin progression in upcoming quarterly prints.
Capillary Q2 FY27: Revenue Up 51% YoY to ₹271.4 Cr; PAT Swings to ₹21.9 Cr
Capillary Technologies reported Q2 FY2027 operating revenue of ₹271.35 Cr (₹2,713.5 Mn), up 51% YoY and 6% QoQ, driven by existing client expansion and the SessionM acquisition. Adjusted EBITDA doubled YoY to ₹44.86 Cr (+103% YoY), maintaining strong operating profitability. The company posted a net profit of ₹21.92 Cr for Q2 FY2027, recovering sharply from a net loss of ₹9.55 Cr in Q1 FY2027. Management highlighted that SessionM, acquired in May 2026 from Mastercard, reached breakeven alongside an on-track integration.
உச்சம் நம்பிக்கை
என்ன மாறியதுCapillary released its financial results press release for Q2 and H1 FY2027, marking a turn to profitability after last quarter's loss.
ஏன் இது முக்கியம்Demonstrates rapid inorganic scaling via the SessionM integration reaching breakeven, accelerating constant-currency SaaS revenue growth and profitability.
📅 குறுகிய காலம்Markets are likely to react positively to the strong top-line growth (+51% YoY) and the swift turnaround from Q1 losses back to healthy positive PAT.
📈 நீண்ட காலம்Platform efficiency via AI-powered migrations and successfully turning acquired units profitable strengthen Capillary's global multi-market SaaS footprint.
⚠ அபாய எச்சரிக்கைகள்
Sustainability of acquisition-led top-line momentum post initial consolidation
Past institutional dissent on compensation schemes (e.g. ESOP ratification)
👀 கவனிக்க வேண்டியவை
Track organic revenue retention rates, the pace of customer migration onto Capillary's platform, and sustaining margin expansion following the SessionM integration.
Capillary Tech Q2 Standalone Revenue Up 81% YoY to ₹84.26 Cr; Appoints Deloitte as Internal Auditor
Capillary Technologies reported Q2 FY27 standalone revenue from operations of ₹84.26 Cr (₹842.58 mn), an 81% increase compared to ₹46.53 Cr in Q2 FY26 and up 31% sequentially from ₹64.29 Cr. Profit before exceptional items and tax on a standalone basis expanded to ₹29.43 Cr compared to a loss of ₹2.97 Cr in the prior-year period. In addition, the board approved the appointment of Deloitte Touche Tohmatsu India LLP as internal auditor, replacing Protiviti. Notes also disclosed an earlier Q1 cyber fraud loss of ₹33.39 Cr (€3.04 mn) in a Czech subsidiary, where forensic investigation concluded without adverse internal findings.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved Q2 FY27 financial results and replaced internal auditor Protiviti with Big Four firm Deloitte to handle international scale.
ஏன் இது முக்கியம்Demonstrates strong top-line momentum in the core standalone business and upgrades corporate governance/audit oversight across expanding global operations.
Standalone Revenue (Q2): ₹842.58 millionStandalone PBT (Q2): ₹294.31 millionCzech subsidiary fraud loss (Q1): ₹333.86 millionUnutilized IPO Proceeds: ₹1,758.55 million
📅 குறுகிய காலம்Strong standalone operating revenue growth will likely support sentiment, though investors will parse consolidated bottom-line performance.
📈 நீண்ட காலம்Upgrading governance by bringing in Deloitte reflects scaling overseas operations, but internal control over foreign subsidiaries remains critical following the European cyber incident.
⚠ அபாய எச்சரிக்கைகள்
Exposure to foreign operational risks highlighted by the ₹33.39 Cr banking fraud in Czech subsidiary
Pending insurance recovery on exceptional losses
👀 கவனிக்க வேண்டியவை
Track the full consolidated earnings print for comprehensive margins and monitor progress on the ₹33.39 Cr cyber-fraud insurance recovery.
KPMG Forensic Audit Confirms EUR 3.04M Cyber Fraud at Capillary's Step-Down Unit
Capillary Technologies disclosed the executive summary of a forensic audit report by KPMG regarding a payment-diversion cyber fraud at step-down subsidiary Session M Czech Republic s.r.o. The investigation confirmed four disputed payments totaling EUR 3,041,169.90 (~Rs 27-28 Cr) executed between June 26, 2026, and July 2, 2026. KPMG found that the fraud was executed via external impersonation using a lookalike domain (law-ogier.co.uk) and off-channel messaging, rather than internal technical or endpoint compromises. While internal wrongdoing was not identified on reviewed laptops, fund recovery remains uncertain as onward fund tracing was outside the forensic scope.
உச்சம் நம்பிக்கை
என்ன மாறியதுKPMG delivered its forensic report detailing the methodology of the EUR 3.04M payment diversion fraud at subsidiary Session M Czech Republic s.r.o.
ஏன் இது முக்கியம்The lost amount of EUR 3.041M (~Rs 27-28 Cr) is material compared to TTM PAT of Rs 42 Cr, posing a direct financial hit unless recovered through insurance or legal remedies.
Total disputed payments: EUR 3,041,169.90Number of fraudulent payments: 4Disputed payments vs TTM PAT (Rs 42 Cr): ~65%Incident transaction period: 26 ஜூன் 2026 to 2 ஜூலை 2026
📅 குறுகிய காலம்Negative sentiment around internal treasury controls and potential P&L provisioning in upcoming quarters for the unrecovered funds.
📈 நீண்ட காலம்Clearance of internal technical compromise reduces existential cybersecurity fears, but highlights the necessity of tighter payment verification controls across foreign subsidiaries.
⚠ அபாய எச்சரிக்கைகள்
Uncertain fund recovery and onward tracing outside forensic scope
Incomplete telemetry as mobile devices and bank-portal approval logs were not forensically acquired
Direct P&L write-off risk impacting earnings
👀 கவனிக்க வேண்டியவை
Track whether the company pursues legal or insurance recoveries, and watch for provisions or write-offs of the ~EUR 3.04M loss in upcoming quarterly earnings.
Capillary Technologies Appoints William Swift as President – Americas Region
Capillary Technologies India Limited has appointed Mr. William Swift as President – Americas Region and designated him as Senior Management Personnel (SMP), effective October 22, 2026. Mr. Swift joined the group in April 2023 following the acquisition of Brierley, where he was previously CTO and CEO. In his new role, he will oversee company operations across the United States, Canada, Mexico, Central America, and South America. The appointment strengthens leadership in the Americas as Capillary looks to scale its TTM revenue base of ₹811 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. William Swift has been promoted from Chief Technical Architect – North America to President – Americas Region and categorized as Senior Management Personnel.
ஏன் இது முக்கியம்The Americas represent a major target market for enterprise SaaS; elevating a former Brierley CEO consolidates integration and operational focus across the region.
Effective date: அக்டோபர் 22, 2026TTM Revenue Context: ₹811 கோடிMarket Cap Context: ₹4,310 கோடி
📅 குறுகிய காலம்Limited direct market impact as this is an internal promotion and executive formalization.
📈 நீண்ட காலம்Strengthens regional enterprise software sales and execution continuity across North and South America, supporting global growth goals.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in expanding regional SaaS pipeline amidst global IT spending scrutiny
👀 கவனிக்க வேண்டியவை
Track upcoming quarterly financial disclosures for commentary on Americas revenue contribution and regional deal momentum under the updated leadership structure.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Capillary Clarifies ~4% Equity Sale Was PE Investor Exit (Peak XV), Not Founder Divestment
Capillary Technologies clarified that the transaction executed on August 10, 2026, involving approximately 4% of the company's equity share capital by its promoter entity Capillary Technologies International Pte. Ltd. (CTIPL), was done to facilitate an exit for early-stage investor Peak XV Partners. The company emphasized that this was not a divestment or exit by operational founders, whose commitment and alignment remain intact. Following this transaction, other institutional private equity investors continue to hold an aggregate equity stake of over 30% in CTIPL. The company noted that future liquidity events by such PE investors may also take place through CTIPL in line with the holding structure.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company issued a formal clarification regarding the ~4% promoter stake sale on August 10, 2026, confirming it was a PE exit rather than founder selling.
ஏன் இது முக்கியம்Allays market concerns regarding founder commitment and operational stability following the promoter entity's recent block disposal.
Equity share capital sold: ~4%Date of transaction: ஆகஸ்ட் 10, 2026Remaining institutional PE stake in promoter entity (CTIPL): >30%
📅 குறுகிய காலம்Reduces negative sentiment or ambiguity around promoter selling, as the block was confirmed as a standard institutional PE exit.
📈 நீண்ட காலம்Structural overhang remains possible over the medium-to-long term, as remaining PE funds holding >30% in CTIPL may seek future exits.
⚠ அபாய எச்சரிக்கைகள்
Potential supply overhang from future secondary exits by remaining PE investors holding >30% in CTIPL
👀 கவனிக்க வேண்டியவை
Track shareholding patterns and disclosures regarding CTIPL to monitor any further secondary sales by remaining institutional PE investors.
Capillary Q1 FY27: New ACV Grows 75% to ₹92 Cr; Management to Beat ₹1,065 Cr Revenue Guidance
Capillary Technologies reported a strong start to FY27, with trailing 12-month new Annual Recurring Contract Value (ACV) growing 75% to ₹92 crore. The company maintains a healthy Net Retention Rate (NRR) of 111% (116% excluding the largest customer) and a subscription gross margin of 66%. Management indicated they expect to exceed their full-year FY27 guidance of ₹1,065 crore in revenue and ₹172 crore in profitability. The US market remains the primary growth driver, now accounting for 60% of total revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has accelerated its new customer acquisition (ACV growth) and successfully integrated the SessionM acquisition, shifting its revenue mix heavily toward the US market.
ஏன் இது முக்கியம்The 75% growth in new ACV and high NRR suggest strong product-market fit in the global loyalty software space, providing high revenue visibility through long-term (3-7 year) subscription contracts.
📅 குறுகிய காலம்The outlook is positive as management expects to beat previous guidance, and the integration of recent acquisitions appears to be progressing ahead of schedule.
📈 நீண்ட காலம்The structural shift to a US-centric, AI-first loyalty platform with high recurring revenue (90%+) positions the company for steady long-term growth, provided it manages institutional investor concerns regarding ESOPs.
⚠ அபாய எச்சரிக்கைகள்
High institutional dissent (49.7%) on ESOP 2021 ratification
Mention of a recent 'fraud incident' in closing remarks
High server costs in SessionM business (50% of its revenue)
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin trajectory of the SessionM acquisition, which management expects to improve from break-even to 15% EBITDA margin within a year by reducing server costs.
75% New ACV Growth and SessionM Integration Highlight Q1 FY27 Earnings Call
Capillary Technologies reported strong momentum in Q1 FY27, with trailing 12-month new Annual Recurring Contract Value (ACV) growing 75% to ₹92 cr. The company is successfully integrating the SessionM acquisition (closed May 1, 2026), targeting a move from break-even to 15% EBITDA margins within a year by optimizing server costs. Management expressed high confidence in exceeding their FY27 guidance of ₹1,065 cr in revenue and ₹172 cr in EBITDA. Despite a mentioned 'fraud incident', the core business remains robust with a Net Retention Rate (NRR) of 111%.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned to a US-heavy revenue mix (60%) and significantly accelerated new contract wins compared to the flat growth seen in FY26.
ஏன் இது முக்கியம்The shift toward high-margin subscription revenue (66% gross margin) and successful integration of global acquisitions like SessionM and Kognitiv are critical for reaching the ₹172 cr EBITDA target.
📅 குறுகிய காலம்Positive sentiment is expected as management confirmed they will beat their annual revenue and EBITDA guidance, supported by strong new logo wins.
📈 நீண்ட காலம்The company is positioning itself as a global leader in AI-first loyalty software; long-term success depends on successfully migrating acquired customers to the core Capillary platform.
⚠ அபாய எச்சரிக்கைகள்
High institutional investor dissent (49.7%) regarding ESOP schemes
Mention of a 'fraud incident' during the call
High server cost concentration in the SessionM business (50% of its revenue)
👀 கவனிக்க வேண்டியவை
Watch for the execution of the SessionM margin recovery plan and the specific impact of the 'fraud incident' mentioned by management in future filings. Monitor if the company can maintain the 30-40% ACV growth rate projected for the full year.
43% Revenue Growth in Q1 FY27; Adj. EBITDA up 132% to ₹44 Cr despite Exceptional Loss
Capillary Technologies reported a robust 43% YoY revenue growth to ₹256.64 cr for Q1 FY27, underpinned by 111% organic Net Revenue Retention (NRR). Adjusted EBITDA surged 132% to ₹44.02 cr as operating expenses (excluding COGS) rose only 32%, demonstrating significant operating leverage. Despite strong operational performance, the company recorded a net loss of ₹9.55 cr due to a one-time exceptional expense of ₹33.39 cr. Growth was further bolstered by a 75% YoY increase in new Annual Contract Value (ACV) and the integration of the SessionM acquisition.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company successfully integrated the SessionM acquisition (closed May 1st) and demonstrated strong organic growth and operating leverage in the first quarter of FY27.
ஏன் இது முக்கியம்High NRR and ACV growth indicate strong product-market fit and expansion within existing enterprise accounts, while the margin expansion on acquired entities provides a clear path to long-term profitability.
📅 குறுகிய காலம்The market is likely to react positively to the strong top-line and EBITDA growth, though the bottom-line loss due to exceptional items may temper immediate gains.
📈 நீண்ட காலம்Structural shift towards higher-margin subscription revenue and successful M&A integration could significantly re-rate the business over the next several quarters.
⚠ அபாய எச்சரிக்கைகள்
Integration risk of SessionM and Kognitiv acquisitions
High institutional investor dissent (49.7%) on ESOP schemes
Impact of one-time exceptional expenses on reported PAT
👀 கவனிக்க வேண்டியவை
Monitor the migration timeline of acquired SessionM and Kognitiv customers to the Capillary platform; management expects this to improve their gross margins from ~30% to ~65%.
Capillary Acquires CustomerGlu to Scale AI Loyalty for 1.9 Billion+ Consumers
Capillary Technologies has acquired the CustomerGlu software platform and associated intellectual property from Delaware-based Marax AI, Inc. through an asset purchase agreement. The acquisition integrates gamification and GenAI-driven interactive engagement into Capillary's existing loyalty stack, which currently serves over 1.9 billion consumers globally. While the transaction value was not disclosed, the move is designed to eliminate IT bottlenecks for enterprise clients, allowing marketers to launch real-time interactive experiences like challenges and streaks.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுCapillary has formally acquired the CustomerGlu platform, adding a gamification and interactive engagement layer to its AI-driven loyalty suite.
ஏன் இது முக்கியம்This acquisition strengthens Capillary's competitive position in the global SaaS loyalty market by enabling real-time, marketer-led digital experiences, potentially increasing platform stickiness and ARPU.
📅 குறுகிய காலம்The market is likely to view this as a positive strategic expansion of the product portfolio, though the lack of financial disclosure on the deal size may limit immediate price movement.
📈 நீண்ட காலம்Structurally significant as it moves Capillary toward a more comprehensive 'marketer-first' platform, reducing client friction and potentially accelerating global market share gains.
⚠ அபாய எச்சரிக்கைகள்
Integration risk of new technology platform
Undisclosed acquisition cost and valuation
High institutional investor dissent (49.7%) noted in previous filings
👀 கவனிக்க வேண்டியவை
Watch for the integration timeline of CustomerGlu into Capillary's core SaaS offering and any subsequent impact on client retention or new enterprise contract wins in the next 2-3 quarters.
₹33.39 Cr Cyber Fraud Reported; Standalone Revenue Up 52% YoY to ₹64.29 Cr
Capillary Technologies reported a strong standalone operational performance for Q1 FY27, with revenue growing 51.9% YoY to ₹64.29 cr and turning a standalone profit of ₹7.77 cr. However, the results are overshadowed by a major cyber-enabled banking fraud in its Czech Republic subsidiary, resulting in an unauthorized transfer of ₹33.39 cr (€3.04 million). This loss has been recognized as an exceptional item in the consolidated results. The company still holds ₹203.22 cr in unutilized IPO proceeds, primarily earmarked for inorganic growth and cloud infrastructure.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company transitioned from a standalone loss to a profit YoY while simultaneously disclosing a significant one-time loss due to international banking fraud.
ஏன் இது முக்கியம்The standalone growth validates the business model's scalability, but the fraud loss (representing ~52% of quarterly standalone revenue) significantly impacts consolidated earnings and raises questions about global operational oversight.
Standalone Revenue (Q1 FY27): ₹642.87 millionStandalone PAT (Q1 FY27): ₹77.65 millionCyber Fraud Loss: ₹333.86 millionFraud Loss vs Standalone Revenue: 51.93%Unutilized IPO Proceeds: ₹2,032.17 million
📅 குறுகிய காலம்The stock may face downward pressure due to the material impact of the cyber fraud on consolidated profitability and sentiment regarding internal controls.
📈 நீண்ட காலம்Structural growth in revenue is positive; however, long-term value will depend on the company's ability to secure international operations and effectively deploy the remaining ₹203 cr IPO proceeds for growth.
⚠ அபாய எச்சரிக்கைகள்
Cyber-security and internal control breach in international subsidiary
High institutional investor dissent (49.7%) on ESOP schemes noted in context
Concentration of IPO proceeds in unutilized fixed deposits
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the forensic investigation into the Czech subsidiary fraud and the recovery of the ₹4.67 cr currently frozen by authorities. The core business shows strong standalone growth, but internal control risks in international operations are now a key concern.
Capillary Technologies Appoints KPMG for Forensic Audit Over Suspected Banking Fraud
Capillary Technologies has formally initiated a forensic audit following suspected fraudulent and unauthorized banking transactions, as disclosed on July 31, 2026. The company has appointed KPMG Assurance and Consulting Services LLP to investigate the root cause and assess internal financial controls. This follows a preliminary intimation on July 06, 2026. While the company reported a net profit of ₹7.99 cr in the Dec 2025 quarter, the total financial exposure from this incident remains undisclosed.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has escalated its response to a suspected banking fraud by appointing an external Big Four firm (KPMG) for a formal forensic investigation.
ஏன் இது முக்கியம்This indicates a potential breach in internal financial controls. Given the company's relatively thin quarterly margins (₹7.99 cr PAT on ₹184 cr revenue), any significant fraud could materially impact the bottom line and investor confidence.
Dec 2025 Quarterly Revenue: ₹184.035 கோடிDec 2025 Net Profit: ₹7.991 கோடிInstitutional Dissent on ESOPs: 49.7440%Initial Incident Disclosure Date: ஜூலை 06, 2026
📅 குறுகிய காலம்The stock is likely to remain under pressure or exhibit volatility until the financial impact of the 'unauthorised banking transactions' is quantified.
📈 நீண்ட காலம்The audit outcome will be critical in determining if this was an isolated fraud or a systemic governance failure, which could affect the company's ability to attract institutional capital.
⚠ அபாய எச்சரிக்கைகள்
Internal financial control failure
Unquantified financial loss
High institutional investor dissent
Reputational risk
👀 கவனிக்க வேண்டியவை
Investors should monitor upcoming disclosures for the forensic audit's findings and the specific quantum of financial loss. The impact on internal control ratings and potential regulatory scrutiny from SEBI are key factors to watch.
EUR 3.0 Million Cyber Fraud at Overseas Subsidiary; EUR 0.45 Million Recovered
Capillary Technologies reported a sophisticated cyber-enabled banking fraud at a recently acquired overseas subsidiary, involving the fraudulent transfer of approximately EUR 3.0 million (approx. ₹27 crore). The attackers used advanced deep-fake methodologies, including voice cloning and signature forging, to impersonate Key Managerial Personnel (KMPs). The company has recovered EUR 0.45 million to date and has placed holds on additional traced funds, though the exact amount on hold is yet to be determined. While the company is covered by cyber insurance, the net financial impact remains under assessment as recovery efforts continue.
உச்சம் நம்பிக்கை
என்ன மாறியதுAn overseas subsidiary was targeted by a deep-fake cyber fraud resulting in a significant unauthorized fund transfer.
ஏன் இது முக்கியம்The fraud amount (approx. ₹27 crore) is more than triple the company's last reported quarterly profit (₹7.99 crore), posing a significant risk to the bottom line if insurance or recovery efforts fail.
Fraud Amount: EUR 3.0 millionRecovered Amount: EUR 0.45 millionDec 2025 Quarterly PAT: ₹7.991 கோடிEstimated Fraud vs Dec 2025 Revenue: ~14.7%Estimated Fraud vs Dec 2025 PAT: ~337%
📅 குறுகிய காலம்Expect negative pressure on the stock as the market digests the potential one-time loss and concerns over internal controls at acquired entities.
📈 நீண்ட காலம்The structural impact depends on the final net loss after insurance; however, it highlights the operational risks of global expansion and the need for robust cyber-security protocols.
⚠ அபாய எச்சரிக்கைகள்
Internal control failure
Cyber security risk
Significant impact on profitability
Uncertainty of insurance recovery
👀 கவனிக்க வேண்டியவை
Monitor future disclosures regarding the final recovery amount and the percentage of the loss covered by insurance. Investors should also look for management commentary on improved internal controls and financial oversight for overseas subsidiaries.
Capillary Technologies Head of Finance Ravi Jaswani Resigns Effective June 5, 2026
Capillary Technologies India Limited has announced the resignation of Mr. Ravi Jaswani, who served as the Head of Finance and a Senior Management Personnel. The resignation was officially communicated on May 29, 2026, with his final working day set for June 05, 2026. Mr. Jaswani is leaving the organization to pursue new professional challenges and opportunities outside the company. The company has not yet announced a successor for this key financial leadership position.
முக்கிய அம்சங்கள்
Mr. Ravi Jaswani has resigned from his role as Head - Finance (Senior Management Personnel).The resignation is effective from the close of business hours on June 05, 2026.The announcement was made on May 29, 2026, indicating a very short transition period of 7 days.The reason cited for the departure is to pursue new challenges and opportunities.
👀 கவனிக்க வேண்டியவை
Investors should monitor for the appointment of a new Head of Finance to ensure continuity in financial reporting and strategy. The short notice period for a senior finance role warrants a cautious watch on upcoming quarterly filings.
Capillary Technologies Unveils AI-Native Strategy and Global Expansion Roadmap
Capillary Technologies is transitioning into an AI-native company, leveraging its 'aiRA' suite to automate loyalty and engagement for over 415 global brands. The company currently manages 1.9 billion+ consumers across 49 countries and was recently recognized as a 'Leader' in the Forrester Wave Q4 2025 report. Key strategic shifts include moving toward usage-based AI pricing and reducing campaign execution times from days to minutes. The presentation outlines a long-term value creation path toward FY30 through both organic growth and strategic M&A.
முக்கிய அம்சங்கள்
Recognized as a 'Leader' in Forrester Wave (Q4 2025) with a 5/5 score in 22 out of 27 criteria.Global footprint includes 415+ brands, 1.9 billion+ consumers, and 20 Fortune 500 customers across 49 countries.Transitioning to an AI-native model with the 'aiRA' suite, reducing campaign cycle times from 2-3 days to just minutes.Platform handles 10 billion+ transactions per year with a 99.999% product uptime.Implementing new AI-native pricing models based on usage and outcomes to scale with customer growth.
👀 கவனிக்க வேண்டியவை
Investors should monitor the adoption of the new AI-native pricing models and the company's ability to execute its inorganic growth playbook. The 'Leader' status in global analyst reports provides a strong competitive moat in the high-growth APAC and mature North American markets.
Capillary Tech FY26 Revenue Up 23%; Q4 EBITDA Margin Hits 19% Amid Major M&A and $20M Deal
Capillary Technologies delivered a strong FY26 with 23% revenue growth and a 14.7% adjusted EBITDA margin, which expanded to 19% in Q4. The company maintained a healthy organic Net Retention Rate of 114%, driven by AI stack adoption and platform usage. A major milestone was the $35 million acquisition of SessionM from Mastercard, which is expected to push the company's Annual Recurring Revenue (ARR) to $115 million within 18 months. Additionally, the company secured a significant $20 million contract with a Fortune 50 retailer, signaling strong momentum in the US market.
முக்கிய அம்சங்கள்
Full-year FY26 revenue grew 23% YoY, with Q4 growth accelerating to 26%Adjusted EBITDA margin improved to 19% in Q4 FY26 compared to 14.7% for the full yearOrganic Net Retention Rate (NRR) stood at 114%, while overall NRR including acquisitions was 110%Completed the $35 million acquisition of SessionM, adding 40+ logos and 5 Fortune 500 clientsSigned a landmark $20 million, 5-year deal with a Fortune 50 retailer in March 2026
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration of SessionM and the migration of its customers to the high-margin Capillary platform. The strong organic NRR and AI-led product traction suggest robust long-term scalability and margin expansion potential.
Capillary Technologies FY26 Revenue Up 23% to ₹7,346 Mn; Normalised PAT Surges 128%
Capillary Technologies reported a robust performance for FY26, with revenue from operations growing 23% YoY to ₹7,346 million. The company demonstrated significant operating leverage as Adjusted EBITDA grew 43% YoY to ₹1,069 million, while Normalised PAT surged 128% to ₹322.8 million. Growth was driven by a strong organic Net Revenue Retention (NRR) of 114% and a landmark $20M+ five-year deal with a US Fortune 50 retailer. The acquisition of SessionM, adding $35M in ARR, further strengthens its global market position.
முக்கிய அம்சங்கள்
FY26 Revenue grew 23% YoY to ₹7,346 Mn, with Q4 FY26 revenue rising 26% to ₹1,913.5 Mn.Normalised PAT for FY26 increased by 128% YoY to ₹322.8 Mn, reflecting improved unit economics.Annual Recurring Revenue (ARR) reached ₹7,654 Mn, supported by a healthy organic NRR of 114%.Closed SessionM acquisition on May 1st, adding $35M ARR and 5 Fortune 500 customers.Secured a 5-year strategic partnership with a US Fortune 50 retailer worth over $20M in March 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor the successful integration of SessionM and the migration of acquired customers to Capillary's higher-margin platform as primary margin drivers. The company's breakthrough into the US Fortune 50 market signals strong global competitiveness for its AI-powered loyalty suite.
Capillary Technologies Q4 FY26 Revenue Up 26% YoY; Normalized FY26 PAT Jumps 128%
Capillary Technologies reported a strong performance for FY2026, with annual operating revenue growing 23% to ₹7,346 million. The company's profitability saw a significant boost, with Normalized PAT surging 128% YoY to ₹322.8 million, driven by operational efficiencies and the integration of the Kognitiv acquisition. Q4 FY26 specifically showed robust growth with revenue up 26% and Adjusted EBITDA up 28% YoY. The recent acquisition of SessionM from Mastercard is expected to further strengthen its global market position and Fortune 500 client base.
முக்கிய அம்சங்கள்
Full-year FY26 Operating Revenue grew 23% YoY to ₹7,346.0 million.Normalized PAT for FY26 increased by 128% YoY to ₹322.8 million.Adjusted EBITDA for the full year reached ₹1,069.2 million, representing a 43% YoY growth.Q4 FY26 PAT saw a massive 233% jump to ₹433.6 million, though normalized growth was 51%.Successful integration of Kognitiv and the acquisition of SessionM from Mastercard are key strategic drivers.
👀 கவனிக்க வேண்டியவை
Investors should view the strong growth in normalized profit and successful M&A integration as positive indicators of the company's SaaS scalability. Monitor the impact of the SessionM acquisition on future margins and global market share expansion.
Capillary Technologies Q4 PAT Jumps 40% to ₹98.95 Mn; Revenue Up 31% YoY
Capillary Technologies reported a strong performance for the quarter ended March 31, 2026, with standalone revenue growing 31.4% YoY to ₹650.23 million. Net profit for the quarter rose significantly by 40% YoY to ₹98.95 million, showcasing strong quarterly momentum. However, on a full-year basis, the annual net profit declined to ₹28.90 million from ₹35.06 million in FY25, despite a 21.7% increase in total annual revenue. The company also announced the appointment of Protiviti India Member Private Limited as its internal auditor for FY 2026-27.
முக்கிய அம்சங்கள்
Q4 FY26 standalone revenue from operations rose to ₹650.23 million from ₹494.74 million in Q4 FY25.Quarterly Net Profit (PAT) increased 40% YoY to ₹98.95 million compared to ₹70.63 million.Full-year FY26 revenue reached ₹2,118.90 million, up from ₹1,740.91 million in FY25.Annual Profit After Tax for FY26 stood at ₹28.90 million, a decrease from ₹35.06 million in the previous year.The Board appointed Protiviti India Member Private Limited as Internal Auditors for the 2026-27 financial year.
👀 கவனிக்க வேண்டியவை
Investors should take note of the strong Q4 recovery and revenue growth, though the full-year profit dip warrants a closer look at rising employee benefit expenses. The stock remains a watch for sustained margin improvement in the upcoming quarters.
Capillary Technologies Completes 100% Acquisition of Mastercard's Session M Inc.
Capillary Technologies has successfully finalized the 100% acquisition of Session M Inc. and its subsidiary Session M Czech Republic s.r.o. from Mastercard Inc. The transaction, completed on May 1, 2026, was executed through the company's international subsidiaries, Capillary Pte. Ltd. and Capillary Technologies LLC. This acquisition follows the initial approval and disclosure made on February 24, 2026. The move is expected to significantly bolster Capillary's global presence and loyalty management capabilities by integrating a major platform previously owned by Mastercard.
முக்கிய அம்சங்கள்
Completed 100% acquisition of Session M Inc. and Session M Czech Republic s.r.o.Acquired from global payments leader Mastercard Inc.Transaction finalized on May 1, 2026, following the February 24, 2026, board approval.Execution carried out via wholly-owned subsidiary Capillary Pte. Ltd. and step-down subsidiary Capillary Technologies LLC.
👀 கவனிக்க வேண்டியவை
Investors should view this as a significant strategic expansion; monitor upcoming quarterly results for the impact of this acquisition on consolidated revenue and global market share.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
